-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On July 20, Zhejiang Medical Insurance Bureau issued the "Announcement on the Implementation of the Central Procurement (Phase II) of cardiothoracic surgery and anesthesia medical supplies in medical institutions in Zhejiang Province" (hereinafter referred to as the "Announcement"). According to the
Bulletin, since August 1, 2020, all public medical institutions in the province have purchased winning products online through the Zhejiang Pharmaceutical Procurement Platform.
Zhejiang Medical Institutions cardiothoracic surgery and anesthesiology medical supplies centralized procurement (second phase) winning results applicable to all public medical institutions in the province.
it is understood that on June 23, Zhejiang Pharmaceutical Procurement Platform issued "on the announcement of zhejiang medical institutions cardiothoracic surgery and anesthesiology medical supplies centralized procurement (second phase) product results and related matters notice."
a total of 125 kinds of supplies won the bid, involving Belon Medical, Kehui Medical, Edward Ian Medical, Telefu and other domestic and foreign arms enterprises.
before this, Zhejiang Medical Insurance Bureau issued a notice showing that cardiothoracic surgery and anesthesiology medical supplies centralized procurement (the first phase) of the winning bid has been announced in Zhejiang Province pharmaceutical procurement platform, the results of the winning bid also apply to all public medical institutions in the province.
Since June 1, 2020, all public medical institutions in the province have purchased winning products online through the Zhejiang Pharmaceutical Procurement Platform.
non-winning products that have been purchased and used, to do a good job of cleaning registration and so on, can be used until August 31, 2020.
first price reduction and then negotiate the above two stages of centralized procurement are in accordance with the Zhejiang Medical Insurance Bureau issued "on the issuance of medical institutions in Zhejiang Province cardiothoracic surgery and anesthesia medical supplies centralized procurement work program notice.
some supplies may need to be cut before negotiations can continue.
the above notice shows that for the determination of the reference price, in the last two years, the lowest sales price in the national history, according to the catalog set the base of 10-20%.
products that quote higher than the reference price are directly eliminated. Products
not higher than the reference price, products that belong to the price limit hanging network, included in the proposed winning list;
the comprehensive evaluation of the lowest price of the product simply into the proposed winning list (only take this one product and do not occupy the winning bid quota), all the remaining products, according to the comprehensive score from high to low ranking, according to the number of finalists in turn into the proposed winning directory.
the above notice also requires that, for the determination of the reference price, according to the first phase of the same evaluation unit in the lowest price of the winning product and the product in the last two years of the national historical minimum sales price fell by 20% after the low value.
the price of products higher than the reference price elimination, the rest of the products regardless of the price limit hanging network products or competitive products, are taken from the evaluation unit relative to the reference price of the largest decline in one into the proposed winning list.
attachments: